Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhaoyi Chen

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Frontiers in Cardiovascular Medicine|August 2, 2024
Impact of hypertensive heart disease, risk factors, and age-period-cohort models across 204 nations and regions from 1990 to 2019: a global perspective from the 2019 global burden of disease studyGuoliang Gao, Zhaoyi Chen, Guoping Yan, et al.
Biomedicine Hub|January 29, 2020
Trends in Gene Expression Profiling for Prostate Cancer Risk Assessment: A Systematic ReviewZhaoyi Chen, Travis Gerke, Victoria Bird, et al.
Drug Discovery Today|December 28, 2020
Applications of artificial intelligence in drug development using real-world dataZhaoyi Chen, Xiong Liu, William Hogan, et al.
JCO Clinical Cancer Informatics|November 13, 2024
Usage of the National Cancer Institute Cancer Research Data Commons by Researchers: A Scoping Review of the LiteratureZhaoyi Chen, Erika Kim, Tanja Davidsen, et al.
International Journal of Medical Informatics|July 31, 2021
Challenges in replicating secondary analysis of electronic health records data with multiple computable phenotypes: A case study on methicillin-resistant Staphylococcus aureus bacteremia infectionsInyoung Jun, Shannan N Rich, Zhaoyi Chen, et al.
Immunogenetics|December 14, 2022
Unfavorable immunotherapy plus tyrosine kinase inhibition outcome of metastatic renal cell carcinoma after radical nephrectomy with increased ADAM9 expressionXianglai Xu, Ying Wang, Zhaoyi Chen, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|August 24, 2018
Risk of health morbidity for the uninsured: 10-year evidence from a large hospital center in Boston, MassachusettsZhaoyi Chen, Jae Min, Jiang Bian, et al.
Plos One|September 13, 2019
Clinical correlates of workplace injury occurrence and recurrence in adultsZhaoyi Chen, Mattia Prosperi, Jiang Bian, et al.
Environmental Research|February 28, 2020
Design and methodology challenges of environment-wide association studies: A systematic reviewYi Zheng, Zhaoyi Chen, Thomas Pearson, et al.
Cancer Research and Treatment|April 6, 2023
Favorable Immunotherapy Plus Tyrosine Kinase Inhibition Outcome of Renal Cell Carcinoma Patients with Low CDK5 ExpressionXianglai Xu, Ying Wang, Zhaoyi Chen, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Frontiers in Cardiovascular Medicine|August 2, 2024
Impact of hypertensive heart disease, risk factors, and age-period-cohort models across 204 nations and regions from 1990 to 2019: a global perspective from the 2019 global burden of disease studyGuoliang Gao, Zhaoyi Chen, Guoping Yan, et al.
Biomedicine Hub|January 29, 2020
Trends in Gene Expression Profiling for Prostate Cancer Risk Assessment: A Systematic ReviewZhaoyi Chen, Travis Gerke, Victoria Bird, et al.
Drug Discovery Today|December 28, 2020
Applications of artificial intelligence in drug development using real-world dataZhaoyi Chen, Xiong Liu, William Hogan, et al.
JCO Clinical Cancer Informatics|November 13, 2024
Usage of the National Cancer Institute Cancer Research Data Commons by Researchers: A Scoping Review of the LiteratureZhaoyi Chen, Erika Kim, Tanja Davidsen, et al.
International Journal of Medical Informatics|July 31, 2021
Challenges in replicating secondary analysis of electronic health records data with multiple computable phenotypes: A case study on methicillin-resistant Staphylococcus aureus bacteremia infectionsInyoung Jun, Shannan N Rich, Zhaoyi Chen, et al.
Immunogenetics|December 14, 2022
Unfavorable immunotherapy plus tyrosine kinase inhibition outcome of metastatic renal cell carcinoma after radical nephrectomy with increased ADAM9 expressionXianglai Xu, Ying Wang, Zhaoyi Chen, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|August 24, 2018
Risk of health morbidity for the uninsured: 10-year evidence from a large hospital center in Boston, MassachusettsZhaoyi Chen, Jae Min, Jiang Bian, et al.
Plos One|September 13, 2019
Clinical correlates of workplace injury occurrence and recurrence in adultsZhaoyi Chen, Mattia Prosperi, Jiang Bian, et al.
Environmental Research|February 28, 2020
Design and methodology challenges of environment-wide association studies: A systematic reviewYi Zheng, Zhaoyi Chen, Thomas Pearson, et al.
Cancer Research and Treatment|April 6, 2023
Favorable Immunotherapy Plus Tyrosine Kinase Inhibition Outcome of Renal Cell Carcinoma Patients with Low CDK5 ExpressionXianglai Xu, Ying Wang, Zhaoyi Chen, et al.
Pageof 7